89 related articles for article (PubMed ID: 10765097)
1. Do renal failure and hemodialysis have any effect on the elimination of free and total prostate-specific antigen?
Danişman A; Kiliç S; Kukul E; Yakupoğlu G; Güntekin E; Baykara M; Sevük M
Eur Urol; 2000 May; 37(5):579-81. PubMed ID: 10765097
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of total and free prostate specific antigen in men on hemodialysis.
Sasagawa I; Kubota Y; Hayami S; Adachi M; Nakada T; Miura H; Imai K
J Urol; 1998 Jul; 160(1):83-5. PubMed ID: 9628610
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of prostate specific antigen in men on hemodialysis.
Wolff JM; Ting O; Borchers H; Rohde D; Jakse G
Anticancer Res; 2000; 20(6D):5191-3. PubMed ID: 11326693
[TBL] [Abstract][Full Text] [Related]
4. Effect of terminal renal failure on the ratio of free to total prostate-specific antigen.
Douville P; Tiberi M
Tumour Biol; 1998; 19(2):113-7. PubMed ID: 9486562
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer screening with prostate-specific antigen in hemodialysis patients.
Horinaga M; Kitamura K; Saito S; Ukimura O; Nakanoma T; Okihara K; Kitagawa M; Nakanishi H; Miki T
Urol Int; 2007; 78(4):334-7. PubMed ID: 17495492
[TBL] [Abstract][Full Text] [Related]
6. Prostate-specific antigen in hemodialysis patients and the influence of dialysis in its levels.
Tzanakis I; Kazoulis S; Girousis N; Kagia S; Spandidakis V; Karefillakis N; Georgila M; Cristoulakis I; Hatzilias P; Kallivretakis N
Nephron; 2002 Feb; 90(2):230-3. PubMed ID: 11818714
[TBL] [Abstract][Full Text] [Related]
7. Effects of hemodialysis on prostate-specific antigen.
Monath JR; Burkart JM; Freedman BI; Pittaway DE; Russell GB; Assimos DG
Urology; 1993 Oct; 42(4):398-400. PubMed ID: 7692660
[TBL] [Abstract][Full Text] [Related]
8. Screening for prostate cancer using prostate-specific antigen testing in Japanese men on hemodialysis.
Kurahashi T; Miyake H; Shinozaki M; Oka N; Takenaka A; Hara I; Matsumura Y; Fujisawa M
Int Urol Nephrol; 2008; 40(2):345-9. PubMed ID: 17619159
[TBL] [Abstract][Full Text] [Related]
9. Effect of hemodialysis on serum complexed prostate-specific antigen levels.
Tarhan F; Orçun A; Küçükercan I; Camursoy N; Kuyumcuoglu U
Scand J Urol Nephrol; 2007; 41(5):382-6. PubMed ID: 17853041
[TBL] [Abstract][Full Text] [Related]
10. Shift of the f/t-PSA quotient in relation to renal insufficiency: consequences for the early detection of prostate carcinoma in patients with terminal renal failure.
Fischer K; Hamza A; Wicht A; Loertzer H; Fornara P
Anticancer Res; 2007; 27(4A):1945-8. PubMed ID: 17649801
[TBL] [Abstract][Full Text] [Related]
11. [Influence of renal and hepatic function in the serum concentration of prostate specific antigen].
Morote Robles J; Encabo G; Lorente JA; Peña JA; Raventos C
Actas Urol Esp; 1997 Oct; 21(9):869-73. PubMed ID: 9471870
[TBL] [Abstract][Full Text] [Related]
12. Free and total prostate-specific antigen levels in saliva and the comparison with serum levels in men.
Turan T; Demir S; Aybek H; Atahan O; Tuncay OL; Aybek Z
Eur Urol; 2000 Nov; 38(5):550-4. PubMed ID: 11096235
[TBL] [Abstract][Full Text] [Related]
13. The effects of extracorporeal cardiopulmonary circulation on serum total and free prostate specific antigen levels.
Aksoy Y; Aksoy H; Ceviz M; Yavuz Balci A; Okyar G; Akçay F
Clin Chem Lab Med; 2005; 43(1):64-7. PubMed ID: 15653444
[TBL] [Abstract][Full Text] [Related]
14. PSA levels in patients on hemodialysis treatment.
García-Sánchez C; Corchuelo-Maillo C; Congregado-Ruiz CB; Ocón-Revuelta EM; Osman-García I; Conde-Sánchez JM; Medina-López RA
Arch Esp Urol; 2013 Dec; 66(10):939-44. PubMed ID: 24369188
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of prostate-specific antigen and vitamin D in peritoneal dialysis patients.
Passadakis P; Ersoy F; Tam P; Memmos D; Siamopoulos K; Ozener C; Akçiçek F; Camsari T; Ates K; Ataman R; Vlachojannis J; Dombros N; Utas C; Akpolat T; Bozfakioglu S; Wu GG; Karayaylali I; Arinsoy T; Stathakis C; Yavuz M; Tsakiris D; Dimitriades A; Yilmaz ME; Gültekin M; Karayalçin B; Challa A; Polat N; Oreopoulos DG
Adv Perit Dial; 2004; 20():203-8. PubMed ID: 15384827
[TBL] [Abstract][Full Text] [Related]
16. The role of free to total prostate-specific antigen ratio for prostate cancer in screening patients with total serum levels between 4 and 20 ng/ml.
Wu CT; Chuang CK; Chou CC; Chu SH; Chen HW; Chen CS; Chiang YJ; Liao SK
Chang Gung Med J; 2000 Mar; 23(3):142-8. PubMed ID: 15641217
[TBL] [Abstract][Full Text] [Related]
17. Similar rates of exponential decrease in serum concentrations of free prostate-specific antigen (PSA), PSA complexed to alpha-1-antichymotrypsin, and human glandular kallikrein 2 (hK2) in prostate cancer patients treated with GnRH-analogues.
Björk T; Schalken J; Wittjes W; Ljungberg B; Lilja H
Prostate; 2001 Apr; 47(1):14-20. PubMed ID: 11304725
[TBL] [Abstract][Full Text] [Related]
18. Effect of transrectal ultrasonography of the prostate on serum prostate-specific antigen levels and free/total prostate-specific antigen ratio.
Serel TA; Cetin M; Delibaş N; Celik E; Tahoğlu M
Urol Int; 2000; 64(1):24-6. PubMed ID: 10782028
[TBL] [Abstract][Full Text] [Related]
19. Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serum.
Becker C; Piironen T; Pettersson K; Björk T; Wojno KJ; Oesterling JE; Lilja H
J Urol; 2000 Jan; 163(1):311-6. PubMed ID: 10604382
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of a transdermal testosterone system in men with end stage renal disease receiving maintenance hemodialysis and healthy hypogonadal men.
Singh AB; Norris K; Modi N; Sinha-Hikim I; Shen R; Davidson T; Bhasin S
J Clin Endocrinol Metab; 2001 Jun; 86(6):2437-45. PubMed ID: 11397836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
